National Cancer Institute
National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Skip navigation

Upcoming Calls

Download:

PDF icon

[Printer-friendly PDF Flyer]

Spring 2009 Understanding NCI: Toll-Free Teleconference Series Schedule

 


**Please note: All teleconferences feature a question and answer
session, open to all callers.**

 


 

Please stay tuned to this space for the Fall 2009 Understanding NCI Teleconference Series schedule.

 

Previous Calls

NCI Community Cancer Centers Program: Translating Scientific Advances into the Community
Tuesday, April 21, 2009, from 2:00 - 3:00 p.m. (ET)

Topic:  The speakers discussed how knowledge gained from NCI programs can be translated into a community setting.

Speakers:

Toll-Free Playback: 1-866-457-5714 through May 21, 2009


Promise and Reality of Proteomics
Thursday, March 19, 2009, from 1:00 - 2:00 p.m. (ET)

Topic: The speakers addressed how the biomarker discovery pipeline can turn discoveries into clinical use.

Speakers:

Playback:  A replay is available at http://proteomics.cancer.gov/objects/video/promiseandreality.wmv.


Thursday, January 8, 2009 from 2:00 – 3:00 p.m. (ET)
TARGET
Pediatric Acute Lymphoblastic Leukemia (ALL) Update Teleconference

The National Cancer Institute's (NCI) Office of Advocacy Relations invites representatives from all pediatric cancer or leukemia organizations to learn about new findings from the NCI TARGET program on pediatric high-risk Acute Lymphoblastic Leukemia (ALL). Brief presentations from principal investigators from NCI, St. Jude Children’s Research Hospital, and the Children’s Oncology Group, were followed by an open question and answer session.


Tuesday, December 16, 2008 from 1:00 - 2:00 p.m. (ET)
Transforming Translation: Implementation of the Translational Research Working Group (TRWG) Report

This webinar featured Dr. Lynn Matrisian, TRWG Co-Chair and Special Assistant to the NCI Director, discussing the new NCI initiatives to foster translational research with Ms. Gwen Darien, editor-in-chief of CR magazine and Director of the Survivor and Patient Advocacy Program at the American Association for Cancer Research. A question-and-answer session followed.


Tuesday, December 2, 2008 from 1:00 - 2:00 p.m. (ET)
CIS Partnership Program Update

This call addressed the National Cancer Institute (NCI) decision not to renew the contract for the Cancer Information Service (CIS) Partnership Program once it expires in January, 2010. Featured speakers were: Ms. Lenora Johnson, Director of NCI’s Office of Communications and Education (OCE), Ms. Mary Anne Bright, Associate Director, Office of Public Information and Resource Management, OCE, and Ms. Madeline La Porta, Associate Director, Office of Partnerships and Dissemination Initiatives, OCE.

Additional Questions or Comments?  Email nciciscomments@mail.nih.gov.


Wednesday, November 12, 2008 from 3:00 - 4:00 p.m. (ET)
P.L.A.N.E.T.: 5-Step Guide to Cancer Control Planning and Programming

Ms. Cynthia Vinson, Dissemination and Diffusion Coordinator in NCI's Division of Cancer Control and Population Sciences, Sona Thakkar, Public Health Advisor in the Office of Partnership and Dissemination Initiatives in NCI’s Office of Communications and Education, and Josephine Crisostomo, Project Director for PLANET MassCONECT at the Dana Farber Cancer Institute discussed the features of the Cancer Control P.L.A.N.E.T. website and then participated in a question and answer session.


Wednesday, November 5, 2008 from 3:00 - 4:30 p.m. (ET)
Advocates in Research Working Group Public Comment

PowerPoint Slide Presentation
Text-only Version

NCI wants to hear from all segments of the advocacy community about the best way to involve advocates in research. This is an opportunity to provide public comment on the work of the Advocates in Research Working Group (ARWG). The NCI Director asked the ARWG to provide recommendations on the most effective ways to consistently involve advocates in NCI activities.

To provide public comment at any time please email nciadvocacywg@mail.nih.gov.


Wednesday, October 29, 2008 from 2:00 - 3:00 p.m. (ET)
NCI's Cancer Information Service: Reaching the Community with Evidence-Based Resources

Ms. Mary Anne Bright, Associate Director of NCI's Office of Public Information and Resource Management in the Office of Communications and Education, Ms. Lenora Johnson, Director of the Office of Communications and Education, and Ms. Carolyn Messner, Director of Education & Training at CancerCare, discussed the Cancer Information Service (CIS).


Thursday, September 11, 2008 from 10:00 a.m. - 11:00 a.m., ET
NCI’s New Funded Research Portfolio Web Site

This is an opportunity to explore funding information about research grant and contract awards made by NCI as well as intramural research funding.  This Web site provides access to various NCI budget reports associated with research funding by research categories. It also provides search capability in various ways including a text search of the project abstract and a search of the NIH research categories that are assigned to the projects. The webinar featured Ms. Lisa A. Krueger from NCI's Research Analysis and Evaluation Branch in the Division of Extramural Activities.


Wednesday, September 17, 2008 from 1:00 p.m. - 2:00 p.m., ET
Update for the Advocacy Community from the NCI Director

Dr. John E. Niederhuber, NCI Director, and Mr. Doug Ulman, Chair of NCI Director’s Consumer Liaison Group, provided an update on recent NCI activities for the advocacy community and answered questions from callers.


Tuesday, June 24, 2008 from 2:00 to 3:00 p.m., ET
Global Breast Cancer Clinical Trial,
ALTTO, to Treat Aggressive Form of Disease

Dr. Edith Perez, ALTTO Principal Investigator and an oncologist in the North Central Cancer Treatment Group (NCCTG) at Mayo Clinic in Jacksonville, Fl.; Dr. Jo Anne Zujewski, Senior Investigator in the NCI Cancer Therapy Evaluation Program; and Ms. Judy Perotti, member of the NCCTG Patient Advocacy Committee and NCCTG Breast Steering Committee discussed the ALTTO study.  ALTTO is a global effort in which 8,000 participants in 50 countries across six continents will participate in a clinical trial that aims to test the effectiveness of two agents (trastuzumab and lapatinib) for the treatment of HER2-positive breast cancer. ALTTO will yield the first comparison of these two drugs in the earliest, most treatable stages of breast cancer.  A question and answer session for participants followed.


Wednesday, June 11, 2008 from 1:00 to 2:00 p.m., EST
Addressing the Complexities of Cancer Health Disparities: NCI's Center to Reduce Cancer Health Disparities

The featured speakers was Dr. Sanya Springfield, Director of NCI's Center to Reduce Cancer Health Disparities; Mrs. Mattie Woods, Executive Director, Centers for Healthy Hearts and Souls; and Ms. Mary Jackson Scroggins, Co-Founder and President, In My Sister's Care. A question and answer session for participants followed.


Wednesday, May 21, 2008 from 2:00 to 3:00 p.m., EST
Understanding the Role of NCI's Clinical Trials Advisory Committee

Dr. Sheila Prindiville, Director, Coordinating Center for Clinical Trials, Ms. Susan Leigh, Advocate Member, CTAC; Col. (Ret.) Jim Williams, Advocate Member, CTAC; and Ms. Paula Kim, Advocate Member, Gastrointestinal Steering Committee discussed how recommendations from the Clinical Trials Working Group resulted in the creation of NCI's Coordinating Center for Clinical Trials. A question and answer session followed.


Thursday, April 10, 2008, from 2:00 - 3:00 p.m., EST
Clinical Trials in Your Community: NCI's Community Clinical Oncology Program (CCOPs)

Dr. Lori Minasian, Chief, Community Oncology and Preventive Trials Research Group, Division of Cancer Prevention, NCI; Dr. John Kugler, Principal Investigator, Illinois Oncology Research Association CCOP, Illinois CancerCare; and Ms. Laura Matus, Volunteer Coordinator, Illinois CancerCare spoke about clinical trials in the community setting. A question and answer session for participants followed.


Thursday, March 20, 2008, from 3:00 to 4:00 p.m., EST
Global Burden of Cancer: Partnerships and Progress

The featured speakers were: Dr. Joe Harford, Director of NCI's Office of International Affairs (OIA) and advocate Debra Kirkland who spoke about her global collaborations funded by the Komen for the Cure. A question and answer session for participants followed. To learn more about OIA, visit http://oia.cancer.gov/.


Thursday, February 28, 2008, from 3:30 p.m. - 4:30 p.m., EST
Webinar: Tools to Guide Efforts to Reduce Colorectal Cancer Deaths

The National Cancer Institute's (NCI) Office of Advocacy Relations hosted a webinar on a set of decision support tools developed through NCI funding that can be used to guide evidence-based policies/guidelines and cancer control planning to decrease colorectal cancer deaths through optimal use of cancer control interventions (i.e. screening, treatment, and risk factor modification).

For the first half of the webinar, presenters gave an overview of CISNET. They presented examples of current applications including a cost-effectiveness analysis for the Centers for Medicare and Medicaid (CMS) on the new technology of a DNA stool test for colorectal cancer screening and a new interactive Web site for modeling the impact of reducing risk factors, increasing screening, and chemotherapy dissemination on US mortality through 2020. In the second half of the call, callers were invited to ask questions about how these tools might be applied to issues of specific interest (e.g., cancer control planning in a geographic area, cost-effective screening strategies).


View Archives for teleconferences from 2005 - 2007